Windlas Biotech Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹238.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.32 per cent from ₹233.10 crore. This corresponds to a year-on-year *(YoY) growth of 17.66 per cent.
Operating Profit
Operating Profit stands at ₹25.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.78 per cent from ₹24.37 crore. This corresponds to a year-on-year *(YoY) decline of 1.02 per cent.
PBDT
PBDT stands at ₹28.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.81 per cent from ₹27.67 crore. This corresponds to a year-on-year *(YoY) decline of 3.43 per cent.
Profit Before Tax
Profit Before Tax stands at ₹20.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.00 per cent from ₹19.97 crore. This corresponds to a year-on-year *(YoY) decline of 3.17 per cent.
Net Profit
Net Profit stands at ₹15.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.60 per cent from ₹15.00 crore. This represents a 1.78 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Windlas Biotech Ltd Earnings
- YOY
- QOQ
Windlas Biotech Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Windlas Biotech Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Windlas Biotech Ltd Financial Reports
Windlas Biotech Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Windlas Biotech | 0.86% | 1.88% | -8.09% | 3.83% | 2.42% | -12.91% |
| Titan Biotech | 4.99% | 3.77% | -6.57% | 71.22% | 129.83% | 391.59% |
| Indoco Remedies | -2.08% | -7.20% | -3.43% | -2.94% | -21.11% | -17.73% |
| NGL Fine Chem | 10.64% | 23.30% | 24.00% | 23.30% | 108.91% | 124.46% |
| Amrutanjan Healt | 1.25% | 0.39% | -3.01% | -7.84% | -19.04% | -22.29% |
| Hester Bios | -0.67% | 5.49% | 24.66% | 20.89% | 14.00% | 2.62% |
| Lincoln Pharma. | 0.32% | 7.69% | 21.51% | 18.94% | 41.77% | 31.07% |
Company Info
Company Information
Chairman & Independent Director : Vivek Dhariwal
Whole-time Director : Ashok Kumar Windlass
Managing Director : Hitesh Windlass
Joint Managing Director : Manoj Kumar Windlass
Executive Director : Pawan Kumar Sharma
Non-Executive & Non-Independent Director : Prachi Jain Windlass
Non Executive & Independent Director : Gaurav Gulati
Company Sec. & Compli. Officer : Ananta Narayan Panda
Additional Director : Tarashree Singhal